Pharmaceutical Technology
A section of Pharmaceuticals (ISSN 1424-8247).
Section Information
The Pharmaceutical Technology Section is devoted to the description of tools enabling the modulation of interactions between drugs or drug candidates and their specific targets. It concerns all technologies and methods related to the development of a pharmaceutical form using natural, semi-synthetic, and synthetic active and auxiliary substances, production in industry, and use in patients. This includes:
- Drug chemistry
- Process technology
- Innovative instrumentation
- Drug manufacturing
- Drug analysis
- Drug production
- Drug delivery
- Management and analysis of data
- Test and quality control
- Regulatory affairs
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Development of Specific Dosage Form: Wound Dressing (Deadline: 25 December 2024)
- Recent Update of Gastroretentive and Intestinal Drug Delivery Systems (Deadline: 30 December 2024)
- Using In Vitro and Ex Vivo Models to Evaluate Strategies for Drug Delivery Improvement (Deadline: 31 December 2024)
- Pharmaceutical Formulation Characterization Design (Deadline: 5 January 2025)
- Applications of Liquid Chromatography Coupled with Mass Spectrometry (LC-MS/MS) in Drug Analysis (Deadline: 15 January 2025)
- Self-Assembling Nanostructures for Cancer Therapy (Deadline: 20 January 2025)
- Emerging Trends in Inhaled Drug Delivery (Deadline: 20 January 2025)
- Chitosan Based Novel Pharmaceutical Dosage Forms and Drug Delivery Systems (Deadline: 24 January 2025)
- Advancements and Challenges of Intrapleural and Peritoneal Drug Delivery (Deadline: 24 January 2025)
- Bioactive Substances and Skin Health: The Role of Pharmacy and Nutrition—Properties and Technology (Deadline: 25 January 2025)
- Novel Treatments and Technologies for Retinal Diseases (Deadline: 25 January 2025)
- Cyclodextrin-Based Drug Delivery System and Its Pharmaceutical and Biomedical Application 2024 (Deadline: 25 January 2025)
- Preparation Technologies and Dissolution Behaviour of Oral Solids (Deadline: 31 January 2025)
- Tumor Therapy and Drug Delivery (Deadline: 20 February 2025)
- Recent Advances in Inhalation Therapy (Deadline: 20 February 2025)
- Orodispersible Tablets: New Advances in Preparation Technologies (Deadline: 24 February 2025)
- Advances in Pediatric Drug Formulations (Deadline: 25 February 2025)
- The 20th Anniversary of Pharmaceuticals—Nanoparticle Interactions with Cells (Deadline: 25 February 2025)
- Drug and Gene Delivery Strategies for Breast Cancer Therapy (Deadline: 25 February 2025)
- Prospects for the Application of Antibiotics in Drug Delivery Systems: New Advances (Deadline: 25 February 2025)
- Emerging Freeze Drying and Spray Drying Techniques (Deadline: 25 February 2025)
- Advances in Drug Analysis and Drug Development (Deadline: 25 February 2025)
- Drug Delivery across the Blood–Brain Barrier (Deadline: 25 February 2025)
- Nanomedicine with Neuroprotective Activity (Deadline: 25 February 2025)
- Progress of Hydrogel Applications in Novel Drug Delivery Platforms (Deadline: 28 February 2025)
- New Platforms for Cancer Treatment—Emerging Advances (Deadline: 28 February 2025)
- Recent Advances in Amorphous Solid Dispersions: Preformulation, Formulation Strategies, Technological Advancements and Characterization (Deadline: 22 March 2025)
- Stimuli-Responsive Polymeric Nanoparticles for the Treatment of Metabolic and Neurodegenerative Diseases (Deadline: 25 March 2025)
- Magnetic Nanoparticles (MNPs) in Biomedical Applications (Deadline: 25 March 2025)
- Solid-State Chemistry and Drug Delivery Systems (Deadline: 25 March 2025)
- Peptide Biomaterials for Pharmaceutical Applications (Deadline: 25 March 2025)
- Application of 3D Printing Technologies for Drug Delivery (Deadline: 31 March 2025)
- Advanced Nanosystems and Emerging Therapies: Innovations in Tuberculosis Treatment and Drug Resistance (Deadline: 31 March 2025)
- Blood–Brain-Barrier-Penetrating Therapeutics Targeting Intrinsically Disordered Proteins in Neurodegenerative Diseases (Deadline: 10 April 2025)
- Use of Encapsulating Polymers of Active Compounds in the Pharmaceutical Industry (Deadline: 22 April 2025)
- Application of Supercritical Fluids in Pharmaceutical Science (Deadline: 23 April 2025)
- Solubilization and Controlled Release Strategy of Poorly Water-Soluble Drugs 2024 (Deadline: 25 April 2025)
- Plant-Derived Nanotherapeutics and Nanocarriers: Recent Progress and Future Directions (Deadline: 25 April 2025)
- Application of Neuroimaging Biomarkers in the Diagnosis and Treatment of Mental Diseases, 2nd Edition (Deadline: 25 April 2025)
- Recent Advances in Stomach and Intestinal Drug Delivery Systems (Deadline: 30 April 2025)
- Application of Biosensors in Pharmaceutical Research (Deadline: 30 April 2025)
- Polymorphs, Salts, Cocrystals and Cationic Lipid Nanoparticle Complexes in Drug Delivery (Deadline: 20 May 2025)
- Nanotechnology in Biomedical Applications (Deadline: 20 May 2025)
- Recent Strategies for Delivery of Plant-Based Active Ingredients (Deadline: 25 May 2025)
- Advances in Biotechnological Formulations for Skin Disorders: Delivery Strategies and Biocompatibility (Deadline: 30 June 2025)
- Photodynamic Therapy: 3rd Edition (Deadline: 25 July 2025)
